Bringing the fundamentals into focus…
Back to Prestige Consumer Healthcare Inc.
How Prestige Consumer Healthcare Inc. stacks up
PBH · against 379 other Healthcare companies of similar size
Valuation
80/ 100
Near the top of its peers.
Ranked #85 of 380 · scores higher than 76% of peers
Bars: peers in each 10-point band of the valuation score55 peers with a valuation score of 80–89, including PBH · Click a bar to see the companies
Why valuation scores 80?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its free cash flow yield, earnings yield and EBITDA yield, which are stronger than most Healthcare peers.
- more operating profit (EBITDA) for the company's total value: stronger than 71% of peers. EBITDA yield: 7.5% vs peer median 4.0%
- higher earnings for the price paid: stronger than 88% of peers. Earnings yield: 7.3% vs peer median 1.5%
- more free cash flow for the price paid: stronger than 93% of peers. Free cash flow yield: 10.0% vs peer median 0.0%
Metric by metric
Position: dot = PBH, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | PBH | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 370 reported | 7.2% | 2.0% | 88% | 30% | |
| EBITDA yieldHigher is better · 378 reported | 7.5% | 4.4% | 70% | 50% | |
| Free cash flow yieldHigher is better · 190 reported | 10.0% | -0.4% | 92% | 20% | |
| Book yieldHigher is better · 370 reported | 81.7% | 32.7% | 90% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around PBHScores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score